<DOC>
	<DOCNO>NCT02466022</DOCNO>
	<brief_summary>Dexmedetomidine demonstrate benefit sedation , post-operative pain control , less respiratory depression common sedative . Traditionally , dexmedetomidine use large load dose infusion , know cause dose-dependent negative side-effects ( Abdallah et al. , 2013 ) . Single dose dexmedetomidine produce less negative side-effects , still effective sedation reduce post-operative pain ( Jung et al. , 2013 ) . There evidence benefit general anesthesia study exist investigate benefit administer sedation purpose spinal anesthesia , study primarily examine post-operative opioid consumption . The investigator hypothesize single dose dexmedetomidine procedural sedation reduce opioid consumption total knee arthroplasty ( TKA ) .</brief_summary>
	<brief_title>Dexmedetomidine Sedation Total Knee Replacements</brief_title>
	<detailed_description>The investigator plan randomize control trial . Sample . Based literature previous study investigator team ( RQHR # 13-80/USask Bio # 13-232 ) , average reduction opioid consumption dexmedetomidine bolus infusion 50 % . Less data exists single dose . However two randomize control trial ( Kaya et al. , 2010 ; Hong et al. , 2012 ) reduce consumption frequency 55 % 45 % , use 0.5ug/kg 1.0ug/kg respectively . A meta-analysis demonstrated mean difference -10mg v -21mg opioid consumption bolus study vs bolus infusion study 24 hour ( Schnabel et . al 2013 ) . A reduction 50 % recently see study conduct earlier investigator center 24hours bolus infusion ( RQHR # 13-80/USask Bio # 13-232 ) . An expected Patient Controlled Analgesia ( PCA ) consumption 24hours total knee arthroplasty 27mg standard deviation 19mg ( Paul et . al , 2013 ) . Using information , decide 40 % reduction opioid consumption 24hours could expect represent clinically significant result . Subsequent power calculation require sample size 50 ( 25 per arm ) demonstrate 40 % reduction opioid consumption 24 hour , study power 80 % P-value 0.05 . Ethics . Ethics approval obtain University Saskatchewan Biomedical Research Ethics Board , Regina Qu'Appelle Health Region Research Ethics Board . Patients identify one investigator daily surgical slate already access patient care . Informed write consent obtain 50 patient Same-Day Admission Unit one investigator involve patient 's care . Randomization Allocation . Following informed consent one investigator , patient randomize one two group base 1:1 ratio . Sealed envelope prepare Department Anesthesia 's Research Coordinator use web-based random number generator , open researcher ( Dr. Maslany Dr. Vipulananthan ) independent clinical team . The drug prepare resident nurse involved patient 's case ; staff member vary depend available need arises . Surgeons , anesthetist , ancillary staff patient blind patient allocation . Study Drug . The study drug ( require refrigeration ) keep locked Anesthesia office Regina General Hospital . It arrange Pharmacy deliver study drug batch , investigator use track sheet account 25 vial require study . Both Dexmedetomidine Normal saline colorless thus unrecognizable either patient anesthetist . There risk patient delay receive midazolam appropriate time case start . If patient asks sedation time , provide . Procedure . Prior enter operating room , patient familiarize Numerical Rating Scale ( NRS ) instruct use patient control analgesia instruction press PCA demand button NRS pain 4 great . All patient receive 500cc bolus lactate ringer 's solution intravascular volume load spinal anesthetic delivery . Monitors include electrocardiography , non-invasive blood pressure measurement , pulse oximetry , end-tidal carbon dioxide concentration nasal prong monitor respiration . Oxygen deliver 3 litre per min . Using computer-generated randomization table blind staff , patient randomly allocate 1:1 receive 0.5ug/kg dexmedetomidine ( experimental group ) volume normal saline ( control group ) 10 min . The current standard care , though variable , entails patient receive midazolam bolus sedation operation , patient request sedation . For patient request sedation , syringe dexmedetomidine saline run single dose infuse 10 minute . However , midazolam bolus ( 0-4 mg IV ) available anesthetist 's discretion achieve moderate sedation score define American Society Anesthesiology . Bupivicaine 0.75 % 1.7cc ( 12.75mg ) fentanyl 10 microgram administer intrathecally analgesia 5 min infusion complete . The level sensory block assess , per standard care , pinprick ice cube . Motor block assess modify Bromage scale ( 0=no paralysis ; 1=unable raise extend leg ; 2=unable flex knee ; 3=unable flex ankle ) ( Bromage et al . 1964 ) . Rescue phenylephrine ephedrine available anesthesiologist use discretion hypotension . Patients discharge post-anesthetic care unit , per standard practice , discharge criterion meet per modify Aldrete score system . For Total Knee Arthroplasty , average PACU stay would 45-60min . Patients keep meet requirement modify Aldrete score longer , per standard care . Data collection . Baseline characteristic collect Dr. Vipulananthan patient ' chart , include : age , weight , height , sex , duration surgery , baseline heart rate blood pressure . Primary secondary outcome measure collect , include : total morphine consumption 6 , 12 , 24hours , time first morphine request , pain score ( Numerical Rating Scale ) 6 , 12 , 24 hour rest , intraoperative midazolam use , time readiness discharge post-anesthetic care unit , intraoperative post-anesthetic care unit hemodynamics , duration sensory motor blockade two-dermatome sensory regression , recovery L2 dermatome sensation knee flexion , adverse opioid effect nausea , vomit , pruritis , urinary retention , post-operative shivering , patient satisfaction . Analysis . Statistical method include multivariate analysis variance Mann-Whitney U-test compare group . There crossover group result analyse intention treat basis . Sub-group analysis Type II diabetic patient analyzed insulin resistance . Statistical significance accept probability level 0.05 .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>adult 18 year undergoing elective unilateral primary total knee arthroplasty spinal anesthesia American Society Anesthesiologists physical status class I III . include contraindication : Dexmedetomidine , morphine , Spinal Anesthesia , well anybody chronic pain treat opioids prior operation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>